Project Grant HT94252410635
Award Date
6/15/24
Completion Date
6/14/27
Dollars Obligated
$1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Boston, MA 02115, USA
Similar Awards
The federal Project Grant award of $1,072,500.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant is funding research at Tufts University School of Medicine to investigate reducing post-traumatic epilepsy by blocking MIAT signaling in parvalbumin-positive inhibitory GABAergic interneurons. The research aims to transform healthcare for military service members, veterans, and the broader public by addressing critical...
The federal Project Grant award for "NEUROPHYSIOLOGY OF POST-TRAUMATIC EPILEPSY: UNRAVELING EPILEPTOGENESIS SIGNALS BIOMARKERS" was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $860,998 award to The Regents of the University of California, San Francisco (UCSF) supports advanced biomedical research to transform healthcare for military service members, veterans, and the public. The project will investigate...
The Department of the Army Medical Command awarded Tufts University School of Medicine a $813,375 Project Grant through the Military Medical Research and Development program (CFDA 12.420) to investigate metabolic modulation of collagens in the extracellular matrix to preserve GABAergic inhibition after traumatic brain injury. The three-year award beginning August 1, 2022 will support research into medical solutions for traumatic brain injuries sustained on the battlefield. A $813k sub-award...
This $864,498 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research at Brigham & Women's Hospital to target neuroinflammation and promote neurological recovery after traumatic spinal cord injury. The research, which will be conducted from August 2025 to July 2028, aims to transform healthcare for military service members, veterans, and the public through innovative biomedical investigations. Brigham...
This federal Project Grant award of $718,829.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research on the use of ergothioneine and its analog ovothiol A to target traumatic brain injury and comorbid alcohol use disorder. The award was granted to Brigham & Women's Hospital Inc., a prominent academic medical center and research institution in Boston, Massachusetts. The research project aims to investigate...
The federal Project Grant award of $1,715,075.00 was provided by the Defense Health Agency to Beth Israel Deaconess Medical Center, Inc. (Bidmc) under the Military Medical Research and Development (CFDA 12.420) program. The funding supports research on "The Role of TBI Derived DAMPS in Bacterial Pneumonia" over a period from September 30, 2023 to September 29, 2026. As a major academic medical center and teaching hospital, Bidmc has an extensive portfolio of federal grants and...
The Department of the Army Medical Command awarded a $3,099,990 project grant to the Western Institute For Veterans Research under the Military Medical Research and Development program (CFDA 12.420). The grant will fund the MILITARY INJURIES - UNDERSTANDING POST-TRAUMATIC EPILEPSY (MINUTE): BIOINFORMATICS WITH BIG DATA TO EXAMINE MULTIMODAL PTE BIOMARKERS project from September 30, 2021 through September 29, 2025. The project aims to utilize bioinformatics and big data approaches to examine...
The federal Project Grant award titled "PSYCHIATRIC ASPECTS OF POST-TRAUMATIC EPILEPSY" was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $650,000 award will fund biomedical research at The Trustees of Columbia University in the City of New York, Health Sciences Division over a 3-year period from Apr 2025 to Apr 2028. The research aims to investigate innovative medical solutions and transform healthcare for military...
This federal Project Grant award, with a funding amount of $1,155,518.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public, with a focus on innovative research addressing critical health challenges. The specific project, titled "IN VIVO NEUROEPIGENETICS IN COMBAT VETERANS WITH...
This $839,745 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) aims to improve care and outcomes for veterans with post-traumatic epilepsy. The grant was awarded to Baylor College of Medicine, a private health sciences university in Houston, Texas, to conduct research and develop new treatments in this area over the 3-year performance period from May 1, 2024 to April 30, 2027. As a leading academic medical center, Baylor...